Know Cancer

or
forgot password

Flow Cytometric Definition and Prognostic Effects of Multiple Myeloma Cancer Stem Cells


N/A
18 Years
N/A
Open (Enrolling)
Both
Multiple Myeloma

Thank you

Trial Information

Flow Cytometric Definition and Prognostic Effects of Multiple Myeloma Cancer Stem Cells


The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal
cells that is called "cancer or progenitor stem cell". In multiple myeloma to define
immunophenotyping features of these "cancer stem cells" with flow cytometry and to show
their prognostic value and check for any relationship between cancer stem cell
quantification and chemotherapy response are main aims of this study.


Inclusion Criteria:



- New Diagnosed or Relapsed Multiple Myeloma

- Routine Bone Marrow Aspiration will be done

Exclusion Criteria:

- Bone Marrow Aspiration is not Needed

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Treatment Response

Outcome Description:

After 3 courses chemotherapy treatment response

Outcome Time Frame:

3 months

Safety Issue:

Yes

Principal Investigator

Mehmet Ozen, MD

Investigator Role:

Principal Investigator

Authority:

Turkey: Ethics Committee

Study ID:

TR06

NCT ID:

NCT01820546

Start Date:

January 2013

Completion Date:

January 2014

Related Keywords:

  • Multiple Myeloma
  • Multiple Myeloma
  • Neoplasms, Plasma Cell

Name

Location